"Decoding inflammation: glycoprotein a repetition predominant, microRNA-142-3-p, and metastasis associated lung adenocarcinoma transcript 1: as novel inflammatory biomarkers of inflammatory bowel disease".

BACKGROUND: Inflammatory bowel disease (IBD) is a chronic gastrointestinal (GI) condition comprising Crohn's disease (CD) and ulcerative colitis (UC). The pathogenesis involves immune system dysregulation, with increased Th (T helper cell)17 cells and reduced regulatory T cell (Treg) differentiation. Transforming growth factor-ß (TGF-ß) secretion from Tregs helps control inflammation, and its production is regulated by glycoprotein-A repetition predominant (GARP) protein along with non-coding RNAs (ncRNAs) like microRNA(miR)-142-3p and metastasis associated lung adenocarcinoma transcript 1 (MALAT1) long non-coding RNAs (LncRNAs). This study analyzed their expression in IBD. METHODS: Blood samples were collected from 44 IBD patients, and 22 healthy controls (HC). RNA extraction and circular DNA (cDNA) synthesis were performed. Real-time polymerase chain reaction (RT-PCR) measured gene expression of GARP, MALAT1, and miR-142-3p. Correlations and group differences were statistically analyzed. RESULTS: Compared to controls, GARP was downregulated while MALAT1 and miR-142-3p were upregulated significantly in IBD group. GARP and MALAT1 expressions positively correlated in controls. MALAT1 and miR-142-3p expressions positively correlated in IBD group. MALAT1 was downregulated in aged HC but upregulated with smoking history across groups. No correlations occurred between gene expression and gender, diet, infections, or disease activity scores. CONCLUSIONS: Dysregulation of GARP, MALAT1, and miR-142-3p likely contributes to inflammation in IBD by reducing TGF-ß. MALAT1 is linked to smoking and age-related changes. These genes have potential as diagnostic markers or therapeutic targets for personalized IBD treatment.

Multilayered mucoadhesive hydrogel films based on Ocimum basilicum seed mucilage/thiolated alginate/dopamine-modified hyaluronic acid and PDA coating for sublingual administration of nystatin.

The present study establishes an experimental design for the preparation of new bi and tri-layer mucoadhesive sublingual films based on basil (Ocimum basilicum L.) seed mucilage (OBM) as novel plant-polysaccharide for oromucosal administration of nystatin (Nys). The films formulation consists of a drug reservoir-mucoadhesive layer cross-linked via CaCl2, with protective mucoadhesive layers based on thiolated alginate (TA) and polydopamine (PDA). OBM served as a new mucoadhesive polysaccharide in second layers, where the dopamine-modified-hyaluronic acid (DHA) improved the mucoadhesive strength and swelling rate properties. The drug-loaded formulations of trilayer film with PDA coating, and bilayer film with DHA/OBM (1:1) in the second layer, showed the desired mucoadhesion properties (about 69 and 75.3% respectively). The obtained results revealed that the bilayer film containing DHA had a superior swelling degree in the range of 15-19 (g/g). While the PDA coating sample showed the highest resistance to water uptake and erosion. The bilayer film (DHA/OBM with 1:1 ratio) provided a maximum drug release of 86% after 4 h. The selected formulations indicated good mechanical properties with no cytotoxicity.

Synthesis of chemically cross-linked hydrogel films based on basil seed (Ocimum basilicum L.) mucilage for wound dressing drug delivery applications.

The present study aims toward the preparation of pH-sensitive hydrogel films based on basil seed mucilage (OBM) biopolymer as a novel drug delivery system for wound dressing. Various contents of polyvinyl alcohol (PVA), glutaraldehyde (GA) as cross-linker, and glycerol as a plasticizer were incorporated to have an optimal combination of softness and resilience. OBM hydrogel films characterized by FT-IR, thermogravimetric analysis (TGA), morphological analysis by scanning electron microscope (SEM) and their physical properties were discussed on the reportage of the results of several tests: rheology, mechanical tests (stress at maximum load and Young's modulus), O2 permeability and water vapor permeability, gel fraction, water retention capacity and swelling degree measurements. The best results for this work were Mu-Gly2, which has the acceptable swelling degree and gel fraction leading to functional water retention capacity, as well as the selected formulations, which were non-toxic and biocompatible according to the result of cytotoxicity test. The optimized formulations of films were used for loading of Tetracycline hydrochloride (TH) as a model drug, and the release studies showed better results at pH = 8.5 and pH = 7.4 rather than acidic pH.

Synthesis of nanohydrogels based on tragacanth gum biopolymer and investigation of swelling and drug delivery.

The present article deals with preparation of pH responsive nanohydrogels based on tragacanth gum (TG) biopolymer for drug delivery. The nanohydrogels were prepared using different chemical reagents such as 3-aminopropyltriethoxysilane (APTES) modifier and glyceroldiglycidylether (GDE), polyvinyl alcohol (PVA), and glutaraldehyde (GA) as cross-linkers. The obtained nanohydrogels were characterized using different techniques such as scanning electron microscope (SEM), elemental analysis, FT-IR, zeta sizer and thermogravimetric analysis (TGA). The gel content increased with increasing the cross-linkers contents and reached to a maximum of 90%. The swelling behavior of nanohydrogels was investigated in terms of the effect of pH (2.2, 7.4 and 9), temperature (27, 37 and 60°C), and reaction time (2-24h). Loading of Indomethacin (IND) as a model drug showed dependence on the network structure of nanohydrogels. The total in vitro IND release showed dependence on the network structure of nanohydrogels and was in the range of 50-80% at pH 9 after 24h.